{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-8785", "postId": 8785, "name": "Lufax Holding Ltd.", "description": "If you purchased or acquired securities in Lufax between April 7, 2023 and January 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lufax Holding Ltd. (\u201cLufax\u201d or the \u201cCompany\u201d) (NYSE: LU) and reminds investors of the May 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Lufax lacked adequate internal controls; (2) Certain of Lufax\u2019s financial results were materially misstated; and (3) as a result, defendants\u2019 statements about Lufax\u2019s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. Lead Plaintiff Deadline: May 20, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "LU", "legal": { "court": "United States District Court for the Central District of California", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "04/07/2023", "end": "01/26/2025" }, "leadPlaintiffDeadline": "05/20/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/lufax-holding-ltd/", "canonicalUrl": "https://faruqilaw.com/case/lufax-holding-ltd/", "datePublished": "2026-03-23T15:04:57+00:00", "dateModified": "2026-03-23T15:04:57+00:00", "associatedOrganization": { "@id": "case-8785-org" }, "legalService": { "@id": "case-8785-legalservice" }, "hasPart": [ { "@id": "case-8785-faq" }, { "@id": "case-8785-press-list" } ], "legalRepresentation": [ { "@id": "case-8785-attorney-516" }, { "@id": "case-8785-attorney-506" } ] }, { "@type": "Organization", "@id": "case-8785-org", "name": "Lufax Holding Ltd.", "identifier": "LU", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://ir.lufaxholding.com/" }, { "@type": "LegalService", "@id": "case-8785-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-8785-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-8785-legalservice" } }, { "@type": "Person", "@id": "case-8785-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-8785-legalservice" } }, { "@type": "FAQPage", "@id": "case-8785-faq", "mainEntity": [ { "@type": "Question", "name": "Why is Lufax facing a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors allege Lufax made misleading statements about its financial results and internal controls, which affected the accuracy of its reported performance." } }, { "@type": "Question", "name": "What are investors claiming about Lufax\u2019s financial statements?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges that certain financial results were materially misstated, giving investors an inaccurate view of the company\u2019s condition." } }, { "@type": "Question", "name": "What does it mean that Lufax had inadequate internal controls?", "acceptedAnswer": { "@type": "Answer", "text": "It means the company may not have had proper systems in place to ensure accurate financial reporting and compliance." } }, { "@type": "Question", "name": "How can weak internal controls affect Lufax investors?", "acceptedAnswer": { "@type": "Answer", "text": "Weak controls can lead to errors or misstatements in financial reports, potentially misleading investors about risks and performance." } }, { "@type": "Question", "name": "What are investors alleging Lufax failed to disclose?", "acceptedAnswer": { "@type": "Answer", "text": "Plaintiffs claim Lufax did not fully disclose issues with its internal controls and financial reporting accuracy." } }, { "@type": "Question", "name": "How could misstated financial results impact Lufax\u2019s stock price?", "acceptedAnswer": { "@type": "Answer", "text": "When corrections or new information are released, investors may reassess the company\u2019s value, leading to price declines." } }, { "@type": "Question", "name": "What does \u201cmaterially misleading\u201d mean in the Lufax lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "It refers to statements or omissions that could influence an investor\u2019s decision to buy or sell stock." } }, { "@type": "Question", "name": "Who may qualify to participate in the Lufax class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased Lufax securities between April 7, 2023 and January 26, 2025 may be eligible if they suffered losses." } }, { "@type": "Question", "name": "What is the deadline to seek lead plaintiff status in the Lufax lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors seeking appointment as lead plaintiff must file a motion by May 20, 2026." } }, { "@type": "Question", "name": "What is a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "A securities class action allows investors to collectively pursue claims for losses caused by misleading statements or omissions." } }, { "@type": "Question", "name": "What does the term \u201cclass period\u201d mean in a securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The class period is the timeframe during which the alleged misconduct occurred and investors may have purchased the stock." } }, { "@type": "Question", "name": "What is a lead plaintiff in a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "The lead plaintiff is the investor selected by the court to represent all shareholders involved in the case." } }, { "@type": "Question", "name": "Do investors need to pay legal fees to join a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "Most cases are handled on contingency, meaning attorneys are paid only if there is a recovery." } }, { "@type": "Question", "name": "How do investors receive compensation from a securities class action settlement?", "acceptedAnswer": { "@type": "Answer", "text": "If a settlement is reached, investors submit claim forms documenting their trades to receive a portion of the settlement fund." } }, { "@type": "Question", "name": "Can investors take action if they believe they were misled by a company?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, investors may participate in a class action or consult legal counsel to explore their rights and potential claims." } } ] }, { "@type": "NewsArticle", "@id": "case-8785-press-1", "headline": "Lufax Holding Stock Sinks on Earnings and Legal Woes", "url": "https://www.tipranks.com/news/catalyst/lufax-holding-stock-sinks-on-earnings-and-legal-woes", "datePublished": "2026-03-23" }, { "@type": "NewsArticle", "@id": "case-8785-press-2", "headline": "Lufax (NYSE: LU) CTO discloses option and ADS holdings in Form 3", "url": "https://www.stocktitan.net/sec-filings/LU/form-3-lufax-holding-ltd-initial-statement-of-beneficial-ownership-5d837edfacb5.html", "datePublished": "2026-03-18" }, { "@type": "NewsArticle", "@id": "case-8785-press-3", "headline": "PAObank Receives Insurance Agency Licence, Announces the Strategic Partnership with China Ping An Insurance (Hong Kong) and FWD Hong Kong Respectively", "url": "https://thedigitalbanker.com/paobank-receives-insurance-agency-licence-announces-the-strategic-partnership-with-china-ping-an-insurance-hong-kong-and-fwd-hong-kong-respectively/", "datePublished": "2025-03-06" }, { "@type": "NewsArticle", "@id": "case-8785-press-4", "headline": "Auditor drama casts unflattering light on Lufax at already-difficult time", "url": "https://thebambooworks.com/auditor-drama-casts-unflattering-light-on-lufax-at-already-difficult-time/", "datePublished": "2025-02-05" }, { "@type": "ItemList", "@id": "case-8785-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-8785-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-8785-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-8785-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-8785-press-4" } } ] } ] }

Lufax Holding Ltd.

Lufax Holding Ltd.

Join Action
Case Details
Ticker LU
Class Period 04/07/2023 - 01/26/2025
Lead Plaintiff Deadline 05/20/2026
Days Left to Seek Plaintiff
5

If you are a Lufax investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Lufax between April 7, 2023 and January 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lufax Holding Ltd. (“Lufax” or the “Company”) (NYSE: LU) and reminds investors of the May 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Lufax lacked adequate internal controls; (2) Certain of Lufax’s financial results were materially misstated; and (3) as a result, defendants’ statements about Lufax’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

📞 Lead Plaintiff Deadline: May 20, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Lufax Holding Ltd.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771